Elanco's Q3 pet health revenue rises 14% to US$608 million as it lifts 2026 outlook
EN
eFeedLink Newsdesk
The US animal health company raised its full-year revenue and earnings guidance on gains for its Zenrelia and Credelio Quattro pet products.

The US animal health company raised its full-year revenue and earnings guidance on gains for its Zenrelia and Credelio Quattro pet products.